Klarna, a leading global retail bank has signed an agreement to acquire PriceRunner. PriceRunner is a leading comparison shopping service in the Nordic region.

The company has more than 170 employees, businesses in Sweden, Denmark, Norway and the United Kingdom and compares 3.4 million products from 22,500 retailers in 25 countries. During the 12-month period ending on Sep 30, 2021, PriceRunner had revenues amounting to MSEK 460. PriceRunner will bring new features in the form of product reviews, rich product discovery and price comparisons to the Klarna app to enhance the shopping, payments and banking experience for consumers globally.

The transaction is subject to customary regulatory approvals.

Vinge’s team primarily consisted of Johan Larsson, Samra Baytar, Stina Bengtsson, Clara Sohlberg and Robin Fagerström (M&A), Sebastian Örndahl and Johan Wahlbom (Competition), Emma Stuart Beck and Henrik Schön (Financial Regulatory), Cecilia Möller Norsted and Anna-Karin Alin (Litigation), Martin Boström, Lisa Hörnqvist and Karl-Hugo Engdahl (IT/GDPR), Klara Secher and Rebecka Målquist (IP), Isabell Nielsen and Mario Saad (Commercial Agreements), Kamyar Najmi and Benjamin Vafaeian (Banking & Financing), Gustav Lindgren (Employment) and Tove Lövgren Frisk (Compliance).

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025